PCRX
Pacira BioSciences Inc
Halal Rating :
Last Price
$22.38
Last updated:
Market Cap
-
7D Change
5.92%
1 Year Change
-30.71%
Company Overview
Industries
Exchange
Next Earnings Date
Pacira BioSciences Inc is a pharmaceutical company focused on developing, manufacturing, and commercializing non-opioid pain management and regenerative health solutions. Their flagship product is EXPAREL, a local analgesic that provides postsurgical pain control. The company also markets iovera°, a handheld cryoanalgesia device, and ZILRETTA, an extended-release corticosteroid for osteoarthritis knee pain.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $168.57m | $312.79m | - | $4.69m | 0.00% | 1.50% |
| June 30, 2024 | $178.02m | $146.15m | - | $-3634000.0 | 0.00% | 2.49% |
| March 31, 2024 | $167.12m | $157.22m | - | $3.32m | 0.00% | 2.11% |
Company Impact
Help us evaluate Pacira BioSciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.